kynurenine pathway IDO
Selected indexed studies
- IDO/kynurenine pathway in cancer: possible therapeutic approaches. (J Transl Med, 2022) [PMID:35918736]
- Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain. (Gut Microbes, 2021) [PMID:33535879]
- Modulation of T cells by tryptophan metabolites in the kynurenine pathway. (Trends Pharmacol Sci, 2023) [PMID:37248103]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Modulation of T cells by tryptophan metabolites in the kynurenine pathway. (2023) pubmed
- IDO/kynurenine pathway in cancer: possible therapeutic approaches. (2022) pubmed
- Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer. (2024) pubmed
- Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain. (2021) pubmed
- IDO-Kynurenine pathway mediates NLRP3 inflammasome activation-induced postoperative cognitive impairment in aged mice. (2024) pubmed
- Impact of IDO activation and alterations in the kynurenine pathway on hyperserotonemia, NAD(+) production, and AhR activation in autism spectrum disorder. (2023) pubmed
- IDO-1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension. (2025) pubmed
- DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota. (2022) pubmed
- Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis. (2019) pubmed
- Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy. (2022) pubmed